Our Science – Bishop Website

Michael R. Bishop, M.D.

Experimental Transplantation and Immunology Branch Head, Transplant Clinical Research Section Senior Investigator National Cancer Institute Building 10 - Hatfield CRC, Room 4-3152 10 Center Drive Bethesda, MD 20892-1203 Phone:   301-435-2764 Fax:   301-480-4354 E-Mail:   mbishop@mail.nih.gov Link: Other Homepage

Biography

Dr. Bishop received his M.D. from the University of Illinois in 1985. He completed clinical training in internal medicine at Northwestern University in 1988 and a fellowship in hematology and oncology at Loyola University Medical Center in 1991. He was an assistant professor of medicine at the University of Kentucky Medical Center from 1991 to 1992 and an associate professor of medicine at the University of Nebraska Medical Center from 1992 to 1999, where he served as director of the Leukemia and Allogeneic Stem Cell Transplantation Programs. Dr. Bishop joined the Medicine Branch in March 1999 to serve as the clinical head of the Stem Cell Transplantation Program.

Research

View Dr. Bishop's Current Clinical Trials

Clinical Transplantation Therapy

The primary goal of the Clinical Transplantation Therapy Program is to develop and conduct novel clinical trials in allogeneic and autologous stem cell transplantation. These trials are being performed in a programmatic fashion with other members of the Experimental Transplantation and Immunology Branch, as well as with collaborators within the NCI and the NIH. Particular areas of interest within the program include the therapeutic use of T cells to enhance engraftment in the setting of nonmyeloablative preparative regimens and to abrogate graft-versus-host disease and T cell reconstitution. In addition, the program is looking specifically at the use of tumor vaccines in both allogeneic and autologous transplants, with primary focus on B cell malignancies and metastatic breast cancer.

This page was last updated on 6/11/2008.